Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, 10530-10532 [2014-04014]
Download as PDF
10530
Federal Register / Vol. 79, No. 37 / Tuesday, February 25, 2014 / Notices
feed-related illness and product defects
associated with feed for livestock
animals, aquaculture species, and
horses.
LivestockNet and PETNet will be
Web-based portals with the same
functionality, but the questions asked
for each portal will be specific for each.
Users of the individual portals are
expected to be the same officials from
Federal, State, and Territorial Agencies.
Because of the similarity of the portals
and the intended audience for both, the
two individual portals will be housed in
an overall system titled the Animal Feed
Network. PETNet and LivestockNet will
be able to be accessed individually in
the Animal Feed Network, once the user
logs in to the system.
Use of the Animal Feed Network,
including the reporting of incidents by
non-FDA members, will continue to be
voluntary. The Animal Feed Network is
a Web-based system, based in a
proprietary system using CORESHIELD
technology, and will be accessible only
to members via password. PETNet and
LivestockNet will make use of
standardized electronic forms that have
been custom developed for the
individual portals. The two forms share
the following common data elements,
the majority of which are drop down
menu choices: Product details (name of
feed, lot code, product form, and the
manufacturer or distributor/packer (if
known)), the species affected, number of
animals exposed to the product, number
of animals affected, body systems
affected, product problem/defect, date
of onset or the date product problem
was detected, the State where the
incident occurred, the origin of the
information, whether there are
supporting laboratory results, and
contact information for the reporting
member (i.e., name, telephone number
will be captured automatically when
member logs in to the system). For the
LivestockNet form, additional data
elements specific to livestock animals
will be captured: Product details
(indication of whether the feed is a
medicated feed, product packaging, and
intended purpose of the feed), class of
the animal species affected, and
production loss. For PETNet, the only
additional data field is the animal life
stage. The form would be filled out and
submitted by a member in the specified
portal of the Animal Feed Network.
Once the entry is submitted, it will be
available to other members. Thus, the
information will be entered and
received by Animal Feed Network
members in as close to real time as
possible. FDA and the PFP have
designed the form itself to contain only
the essential information necessary to
alert Animal Feed Network members
about animal feed and pet food-related
incidents.
In the Federal Register of August 26,
2013 (78 FR 52774), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. Although four comments
were received, none were responsive to
the four collection of information topics
solicited and therefore will not be
discussed in this document.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED REPORTING BURDEN 1
Number of
respondents
21 U.S.C. Section
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Total hours
21 U.S.C. 342, 21 U.S.C. 343, Section 1002(b) of the
FDA Amendments Act of 2007/PETNet.
Ibid./LivestockNet portal ................................................
20
5
100
0.25 (15 minutes)
25
20
5
100
0.25 (15 minutes)
25
Total Hours .............................................................
........................
........................
........................
..............................
50
emcdonald on DSK67QTVN1PROD with NOTICES
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA estimates that each member will
report to the Animal Feed Network (i.e.,
fill out the PETNet or LivestockNet form
to alert other members about a pet food
or animal food-related incident,
respectively) approximately five times
per year for each portal. This estimate
represents the maximum number of
reports that FDA expects will be
submitted in a year, and in many cases
the number of reports submitted by a
member will probably be far less. FDA
believes that, given the PETNet form has
15 items and the LivestockNet form has
19 items, with most being drop down
fields and not all fields being required
for submission, 15 minutes is a
sufficient amount of time to complete
the form. State regulatory officials
responsible for animal feed and pet food
already possess computer systems and
have the Internet access necessary to
participate in the Animal Feed Network,
and thus there are no capital
expenditures associated with the
reporting.
VerDate Mar<15>2010
17:58 Feb 24, 2014
Jkt 232001
Regarding recordkeeping, State
regulatory officials who report in the
Animal Feed Network receive the
reportable information from consumers
in their States in the course of their
customary and regular duties. Further,
these individuals already maintain
records of such consumer complaints in
the course of their duties which are
sufficient for the purposes of reporting
in the PETNet and LivestockNet portals
of the Animal Feed Network. Therefore,
FDA believes that the proposed
collection of information does not have
additional recordkeeping requirements.
Dated: February 20, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–04012 Filed 2–24–14; 8:45 am]
BILLING CODE 4160–01–P
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–1619]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Current Good
Manufacturing Practice in
Manufacturing, Packaging, Labeling, or
Holding Operations for Dietary
Supplements
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
SUMMARY:
E:\FR\FM\25FEN1.SGM
25FEN1
Federal Register / Vol. 79, No. 37 / Tuesday, February 25, 2014 / Notices
Fax written comments on the
collection of information by March 27,
2014.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0606. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 1350 Piccard
Dr., PI50–400B, Rockville, MD 20850,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
emcdonald on DSK67QTVN1PROD with NOTICES
DATES:
Current Good Manufacturing Practice
(CGMP) in Manufacturing, Packaging,
Labeling, or Holding Operations for
Dietary Supplements—21 CFR Part 111
(OMB Control Number 0910–0606)—
Extension
On October 25, 1994, the Dietary
Supplement Health and Education Act
(DSHEA) (Pub. L. 103–417) was signed
into law. DSHEA, among other things,
amended the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) by adding
section 402(g) of the FD&C Act (21
U.S.C. 342(g)). Section 402(g)(2) of the
FD&C Act provides, in part, that the
Secretary of Health and Human Services
may, by regulation, prescribe good
manufacturing practices for dietary
supplements. Section 402(g) of the
FD&C Act also stipulates that such
regulations will be modeled after CGMP
regulations for food and may not impose
standards for which there are no
current, and generally available,
analytical methodologies. Section
402(g)(1) of the FD&C Act states that a
dietary supplement is adulterated if ‘‘it
has been prepared, packed, or held
under conditions that do not meet
current good manufacturing practice
regulations.’’ Under section 701(a) of the
FD&C Act (21 U.S.C. 371), FDA may
issue regulations necessary for the
efficient enforcement of the FD&C Act.
In the Federal Register of June 25, 2007
(72 FR 34752) (the June 25, 2007, final
rule), FDA published a final rule that
established, in part 111 (21 CFR part
111), the minimum CGMP necessary for
activities related to manufacturing,
packaging, labeling, or holding dietary
VerDate Mar<15>2010
17:58 Feb 24, 2014
Jkt 232001
supplements to ensure the quality of the
dietary supplement.
Records are an indispensable
component of CGMP. The records
required by FDA’s regulations in part
111 provide the foundation for the
planning, control, and improvement
processes that constitute a quality
control system. Implementation of these
processes in a manufacturing operation
serves as the backbone to CGMP. The
records show what is to be
manufactured; what was, in fact,
manufactured; and whether the controls
that the manufacturer put in place to
ensure the identity, purity, strength, and
composition and limits on contaminants
and to prevent adulteration were
effective. Further, records will show
whether and what deviations from
control processes occurred, facilitate
evaluation and corrective action
concerning these deviations (including,
where necessary, whether associated
batches of product should be recalled
from the marketplace), and enable a
manufacturer to assure that the
corrective action was effective. In
addition, by establishing recordkeeping
requirements, FDA can ensure that
industry follows CGMP during
manufacturing, packaging, labeling, or
holding operations. The regulations in
part 111 establish the minimum
manufacturing practices necessary to
ensure that dietary supplements are
manufactured, packaged, labeled, or
held in a manner that will ensure the
quality of the dietary supplements
during manufacturing, packaging,
labeling, or holding operations.
The recordkeeping requirements of
the regulations include establishing
written procedures and maintaining
records pertaining to: (1) Personnel; (2)
sanitation; (3) calibration of instruments
and controls; (4) calibration, inspection,
or checks of automated, mechanical, or
electronic equipment; (5) maintaining,
cleaning, and sanitizing equipment and
utensils and other contact surfaces; (6)
water used that may become a
component of the dietary supplement;
(7) production and process controls; (8)
quality control; (9) components,
packaging, labels, and product received
for packaging and labeling; (10) master
manufacturing and batch production;
(11) laboratory operations; (12)
manufacturing operations; (13)
packaging and labeling operations; (14)
holding and distributing operations; (15)
returned dietary supplements; and (16)
product complaints.
Description of Respondents:
Manufacturers, dietary supplement
manufacturers, packagers and
repackagers, labelers and re-labelers,
holders, distributors, warehousers,
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
10531
exporters, importers, large businesses,
and small businesses engaged in the
dietary supplement industry.
The recordkeeping requirements of
the regulations in part 111 are set forth
in each subpart. In table 1 we list the
annual burdens associated with
recordkeeping, as described in the June
25, 2007, final rule. For some provisions
listed in table 1, we did not estimate the
number of records per recordkeeper
because recordkeeping occasions consist
of frequent brief entries of dates,
temperatures, monitoring results, or
documentation that specific actions
were taken. Information might be
recorded a few times a day, week, or
month. When the records burden
involves frequent brief entries, we
entered 1 as the default for the number
of records per recordkeeper. For
example, many of the records listed
under § 111.35 in table 1, such as
§ 111.35(b)(2) (documentation, in
individual equipment logs, of the date
of the use, maintenance, cleaning, and
sanitizing of equipment), involve many
short sporadic entries over the course of
the year, varying across equipment and
plants in the industry. We did not
attempt to estimate the actual number of
recordkeeping occasions for these
provisions, but instead entered an
estimate of the average number of hours
per year. We entered the default value
of 1 as the number of records per
recordkeeper for these and similar
provisions. For § 111.35, the entry for
number of records is 1 as a default
representing a large number of brief
recordkeeping occasions.
In many rows of table 1, we list a
burden under a single provision that
covers the written procedures or records
described in several provisions. For
example, the burden of the batch
production records listed in table 1
under § 111.260 includes the burden for
records listed under § 111.255 because
the batch production records must
include those records.
The number of records for batch
production records (and other records
kept on a batch basis in table 1) equals
the annual number of batches. The
estimated burden for records kept by
batch includes both records kept for
every batch and records kept for some,
but not all, batches. We use the annual
number of batches as the number of
records that will not necessarily be kept
for every batch, such as test results or
material review and disposition records,
because such records are part of records,
if they are necessary, that will be kept
for every batch.
In the Federal Register of December
19, 2013 (78 FR 76836), FDA published
a 60-day notice requesting public
E:\FR\FM\25FEN1.SGM
25FEN1
10532
Federal Register / Vol. 79, No. 37 / Tuesday, February 25, 2014 / Notices
comment on the proposed collection of
information. No comments were
received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
recordkeepers
21 CFR Section
111.14, records of personnel practices, including documentation of training .......................................................
111.23, records of physical plant sanitation practices, including pest control and water quality ...........................
111.35, records of equipment and utensils calibration and
sanitation practices .........................................................
111.95, records of production and process control systems ................................................................................
111.140, records that quality control personnel must
make and keep ...............................................................
111.180, records associated with components, packaging, labels, and product received for packaging and
labeling as a dietary supplement ...................................
111.210, requirements for what the master manufacturing
record must include ........................................................
111.260, requirements for what the batch record must include ...............................................................................
111.325, records that quality control personnel must
make and keep for laboratory operations ......................
111.375, records of the written procedures established
for manufacturing operations .........................................
111.430, records of the written procedures for packaging
and labeling operations ..................................................
111.475, records of product distribution and procedures
for holding and distributing operations ...........................
111.535, records for returned dietary supplements ..........
111.570, records regarding product complaints ................
Total ............................................................................
emcdonald on DSK67QTVN1PROD with NOTICES
1 There
Number of
records per
recordkeeper
Average burden
per
recordkeeping
Total annual
records
Total hours
15,000
4
60,000
1
60,000
15,000
1
15,000
0.2
3,000
400
1
400
12.5
5,000
250
1
250
45
11,250
240
1163
279,120
1
279,120
240
1163
279,120
1
279,120
240
1
240
145
1408
204,160
1
204,160
120
1
120
15
1,800
260
1
260
2
520
50
1
50
12.6
630
15,000
110
240
1
4
600
15,000
440
144,000
0.4
13.5
0.5
6,000
5,940
72,000
........................
........................
........................
..........................
929,140
2.5
600
are no capital costs or operating and maintenance costs associated with this collection of information.
The average burden per recordkeeping
estimates in table 1 are based on those
in the June 25, 2007, final rule, which
were based on our institutional
experience with other CGMP
requirements and on data provided by
Research Triangle Institute in the
‘‘Survey of Manufacturing Practices in
the Dietary Supplement Industry’’ cited
in that rule.
The estimates in table 1 of the number
of firms affected by each provision of
part 111 are based on the percentage of
manufacturers, packagers, labelers,
holders, distributors, and warehousers
that reported in the survey that they
have not established written standard
operating procedures or do not maintain
records that were later required by the
June 25, 2007, final rule. Because we do
not have survey results for general
warehouses, we entered the
approximate number of facilities in that
category for those provisions covering
general facilities. For the dietary
supplement industry, the survey
estimated that 1,460 firms would be
covered by the final rule, including
manufacturers, packagers, labelers,
holders, distributors, and warehousers.
VerDate Mar<15>2010
17:58 Feb 24, 2014
Jkt 232001
The time estimates include the burden
involved in documenting that certain
requirements are performed and in
recordkeeping. We used an estimated
annual batch production of 1,408
batches per year to estimate the burden
of requirements that are related to the
number of batches produced annually,
such as § 111.260, ‘‘What must the batch
production record include?’’ The
estimate of 1,408 batches per year is
near the midpoint of the number of
annual batches reported by survey
firms.
The length of time that CGMP records
must be maintained is set forth in
§ 111.605. Table 1 reflects the estimated
burdens for written procedures, record
maintenance, periodically reviewing
records to determine if they may be
discarded, and for any associated
documentation for that activity for
records that are required under part 111.
We have not included a separate
estimate of burden for those sections
that require maintaining records in
accordance with § 111.605, but have
included those burdens under specific
provisions for keeping records. For
example, § 111.255(a) requires that the
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
batch production records be prepared
every time a batch is manufactured, and
§ 111.255(d) requires that batch
production records be kept in
accordance with § 111.605. The
estimated burdens for both § 111.255(a)
and (d) are included under § 111.260
(what the batch record must include).
Dated: February 20, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–04014 Filed 2–24–14; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2007–N–0037]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Animal Drug User
Fee Act Waivers and Reductions
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
E:\FR\FM\25FEN1.SGM
Notice.
25FEN1
Agencies
[Federal Register Volume 79, Number 37 (Tuesday, February 25, 2014)]
[Notices]
[Pages 10530-10532]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-04014]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-1619]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Current Good
Manufacturing Practice in Manufacturing, Packaging, Labeling, or
Holding Operations for Dietary Supplements
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
[[Page 10531]]
DATES: Fax written comments on the collection of information by March
27, 2014.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0606.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville,
MD 20850, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Current Good Manufacturing Practice (CGMP) in Manufacturing, Packaging,
Labeling, or Holding Operations for Dietary Supplements--21 CFR Part
111 (OMB Control Number 0910-0606)--Extension
On October 25, 1994, the Dietary Supplement Health and Education
Act (DSHEA) (Pub. L. 103-417) was signed into law. DSHEA, among other
things, amended the Federal Food, Drug, and Cosmetic Act (the FD&C Act)
by adding section 402(g) of the FD&C Act (21 U.S.C. 342(g)). Section
402(g)(2) of the FD&C Act provides, in part, that the Secretary of
Health and Human Services may, by regulation, prescribe good
manufacturing practices for dietary supplements. Section 402(g) of the
FD&C Act also stipulates that such regulations will be modeled after
CGMP regulations for food and may not impose standards for which there
are no current, and generally available, analytical methodologies.
Section 402(g)(1) of the FD&C Act states that a dietary supplement is
adulterated if ``it has been prepared, packed, or held under conditions
that do not meet current good manufacturing practice regulations.''
Under section 701(a) of the FD&C Act (21 U.S.C. 371), FDA may issue
regulations necessary for the efficient enforcement of the FD&C Act. In
the Federal Register of June 25, 2007 (72 FR 34752) (the June 25, 2007,
final rule), FDA published a final rule that established, in part 111
(21 CFR part 111), the minimum CGMP necessary for activities related to
manufacturing, packaging, labeling, or holding dietary supplements to
ensure the quality of the dietary supplement.
Records are an indispensable component of CGMP. The records
required by FDA's regulations in part 111 provide the foundation for
the planning, control, and improvement processes that constitute a
quality control system. Implementation of these processes in a
manufacturing operation serves as the backbone to CGMP. The records
show what is to be manufactured; what was, in fact, manufactured; and
whether the controls that the manufacturer put in place to ensure the
identity, purity, strength, and composition and limits on contaminants
and to prevent adulteration were effective. Further, records will show
whether and what deviations from control processes occurred, facilitate
evaluation and corrective action concerning these deviations
(including, where necessary, whether associated batches of product
should be recalled from the marketplace), and enable a manufacturer to
assure that the corrective action was effective. In addition, by
establishing recordkeeping requirements, FDA can ensure that industry
follows CGMP during manufacturing, packaging, labeling, or holding
operations. The regulations in part 111 establish the minimum
manufacturing practices necessary to ensure that dietary supplements
are manufactured, packaged, labeled, or held in a manner that will
ensure the quality of the dietary supplements during manufacturing,
packaging, labeling, or holding operations.
The recordkeeping requirements of the regulations include
establishing written procedures and maintaining records pertaining to:
(1) Personnel; (2) sanitation; (3) calibration of instruments and
controls; (4) calibration, inspection, or checks of automated,
mechanical, or electronic equipment; (5) maintaining, cleaning, and
sanitizing equipment and utensils and other contact surfaces; (6) water
used that may become a component of the dietary supplement; (7)
production and process controls; (8) quality control; (9) components,
packaging, labels, and product received for packaging and labeling;
(10) master manufacturing and batch production; (11) laboratory
operations; (12) manufacturing operations; (13) packaging and labeling
operations; (14) holding and distributing operations; (15) returned
dietary supplements; and (16) product complaints.
Description of Respondents: Manufacturers, dietary supplement
manufacturers, packagers and repackagers, labelers and re-labelers,
holders, distributors, warehousers, exporters, importers, large
businesses, and small businesses engaged in the dietary supplement
industry.
The recordkeeping requirements of the regulations in part 111 are
set forth in each subpart. In table 1 we list the annual burdens
associated with recordkeeping, as described in the June 25, 2007, final
rule. For some provisions listed in table 1, we did not estimate the
number of records per recordkeeper because recordkeeping occasions
consist of frequent brief entries of dates, temperatures, monitoring
results, or documentation that specific actions were taken. Information
might be recorded a few times a day, week, or month. When the records
burden involves frequent brief entries, we entered 1 as the default for
the number of records per recordkeeper. For example, many of the
records listed under Sec. 111.35 in table 1, such as Sec.
111.35(b)(2) (documentation, in individual equipment logs, of the date
of the use, maintenance, cleaning, and sanitizing of equipment),
involve many short sporadic entries over the course of the year,
varying across equipment and plants in the industry. We did not attempt
to estimate the actual number of recordkeeping occasions for these
provisions, but instead entered an estimate of the average number of
hours per year. We entered the default value of 1 as the number of
records per recordkeeper for these and similar provisions. For Sec.
111.35, the entry for number of records is 1 as a default representing
a large number of brief recordkeeping occasions.
In many rows of table 1, we list a burden under a single provision
that covers the written procedures or records described in several
provisions. For example, the burden of the batch production records
listed in table 1 under Sec. 111.260 includes the burden for records
listed under Sec. 111.255 because the batch production records must
include those records.
The number of records for batch production records (and other
records kept on a batch basis in table 1) equals the annual number of
batches. The estimated burden for records kept by batch includes both
records kept for every batch and records kept for some, but not all,
batches. We use the annual number of batches as the number of records
that will not necessarily be kept for every batch, such as test results
or material review and disposition records, because such records are
part of records, if they are necessary, that will be kept for every
batch.
In the Federal Register of December 19, 2013 (78 FR 76836), FDA
published a 60-day notice requesting public
[[Page 10532]]
comment on the proposed collection of information. No comments were
received.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of Average burden
21 CFR Section Number of records per Total annual per Total hours
recordkeepers recordkeeper records recordkeeping
----------------------------------------------------------------------------------------------------------------
111.14, records of personnel 15,000 4 60,000 1 60,000
practices, including
documentation of training.....
111.23, records of physical 15,000 1 15,000 0.2 3,000
plant sanitation practices,
including pest control and
water quality.................
111.35, records of equipment 400 1 400 12.5 5,000
and utensils calibration and
sanitation practices..........
111.95, records of production 250 1 250 45 11,250
and process control systems...
111.140, records that quality 240 1163 279,120 1 279,120
control personnel must make
and keep......................
111.180, records associated 240 1163 279,120 1 279,120
with components, packaging,
labels, and product received
for packaging and labeling as
a dietary supplement..........
111.210, requirements for what 240 1 240 2.5 600
the master manufacturing
record must include...........
111.260, requirements for what 145 1408 204,160 1 204,160
the batch record must include.
111.325, records that quality 120 1 120 15 1,800
control personnel must make
and keep for laboratory
operations....................
111.375, records of the written 260 1 260 2 520
procedures established for
manufacturing operations......
111.430, records of the written 50 1 50 12.6 630
procedures for packaging and
labeling operations...........
111.475, records of product 15,000 1 15,000 0.4 6,000
distribution and procedures
for holding and distributing
operations....................
111.535, records for returned 110 4 440 13.5 5,940
dietary supplements...........
111.570, records regarding 240 600 144,000 0.5 72,000
product complaints............
--------------------------------------------------------------------------------
Total...................... .............. .............. .............. ............... 929,140
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
The average burden per recordkeeping estimates in table 1 are based
on those in the June 25, 2007, final rule, which were based on our
institutional experience with other CGMP requirements and on data
provided by Research Triangle Institute in the ``Survey of
Manufacturing Practices in the Dietary Supplement Industry'' cited in
that rule.
The estimates in table 1 of the number of firms affected by each
provision of part 111 are based on the percentage of manufacturers,
packagers, labelers, holders, distributors, and warehousers that
reported in the survey that they have not established written standard
operating procedures or do not maintain records that were later
required by the June 25, 2007, final rule. Because we do not have
survey results for general warehouses, we entered the approximate
number of facilities in that category for those provisions covering
general facilities. For the dietary supplement industry, the survey
estimated that 1,460 firms would be covered by the final rule,
including manufacturers, packagers, labelers, holders, distributors,
and warehousers. The time estimates include the burden involved in
documenting that certain requirements are performed and in
recordkeeping. We used an estimated annual batch production of 1,408
batches per year to estimate the burden of requirements that are
related to the number of batches produced annually, such as Sec.
111.260, ``What must the batch production record include?'' The
estimate of 1,408 batches per year is near the midpoint of the number
of annual batches reported by survey firms.
The length of time that CGMP records must be maintained is set
forth in Sec. 111.605. Table 1 reflects the estimated burdens for
written procedures, record maintenance, periodically reviewing records
to determine if they may be discarded, and for any associated
documentation for that activity for records that are required under
part 111. We have not included a separate estimate of burden for those
sections that require maintaining records in accordance with Sec.
111.605, but have included those burdens under specific provisions for
keeping records. For example, Sec. 111.255(a) requires that the batch
production records be prepared every time a batch is manufactured, and
Sec. 111.255(d) requires that batch production records be kept in
accordance with Sec. 111.605. The estimated burdens for both Sec.
111.255(a) and (d) are included under Sec. 111.260 (what the batch
record must include).
Dated: February 20, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-04014 Filed 2-24-14; 8:45 am]
BILLING CODE 4160-01-P